KINSY is pleased to announce our participation in CPhI Japan 2025, one of the premier pharmaceutical industry events in the Asia-Pacific region. This international trade show provides an outstanding opportunity to connect with key strategic partners, explore potential business collaborations, and showcase our expanded CDMO and active pharmaceutical ingredient (API) manufacturing capabilities.
As a trusted European CDMO specializing in custom organic synthesis, we are fully committed to manufacturing high-quality Active Pharmaceutical Ingredients (APIs) and advanced chemical intermediates under strict cGMP international quality standards.
Advanced CDMO Services and Solutions
Our presence at CPhI Japan 2025 highlights our ongoing commitment to international expansion and supporting global pharmaceutical innovations. At KINSY, we offer comprehensive, flexible, end-to-end services tailored to every stage of drug development and commercialization for our international clients:
- Synthetic Route Optimization: Developing highly efficient, scalable, and cost-effective manufacturing processes.
- Pilot Plant Scaling: Ensuring rapid, safe, and seamless technology transfer while maintaining full regulatory compliance.
- Commercial API Production: Utilizing versatile, multi-purpose industrial facilities designed to meet high-volume global market demands.
Schedule a Meeting with Our Technical Team
If you are attending the exhibition and seeking a dependable European CDMO partner for your commercial or clinical molecule manufacturing needs, we invite you to meet directly with our team of technical specialists. We look forward to discussing your upcoming project goals, addressing technical queries, and presenting our advanced analytical, regulatory, and industrial production capabilities.
To coordinate a business meeting prior to the event, please contact KINSY or explore our updated product catalog.
For additional details regarding the official event schedule, venue location, and conference program, please visit the official CPhI Japan 2025 website.
